Abstract
Real-world safety and effectiveness of velaglucerase alfa in pediatric patients with Gaucher disease younger than 4 years of age: A combined retrospective and prospective cohort study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have